Allosteric regulation of G-protein-coupled receptors: from diversity of molecular mechanisms to multiple allosteric sites and their ligands
AO Shpakov - International Journal of Molecular Sciences, 2023 - mdpi.com
Allosteric regulation is critical for the functioning of G protein-coupled receptors (GPCRs)
and their signaling pathways. Endogenous allosteric regulators of GPCRs are simple ions …
and their signaling pathways. Endogenous allosteric regulators of GPCRs are simple ions …
Genomic Risk Factors for Urethral Stricture: A Systematic Review and Gene Network Analysis
Objectives To identify genes that may play a role in urethral stricture and summarize the
results of studies that have documented variations in gene expression among individuals …
results of studies that have documented variations in gene expression among individuals …
The CXCL10/CXCR3 Pathway contributes to the synergy of thermal ablation and PD-1 Blockade Therapy against Tumors
W Xiao, H Huang, P Zheng, Y Liu, Y Chen, J Chen… - Cancers, 2023 - mdpi.com
Simple Summary Thermal ablation has been confirmed to increase the percentage of
functional CD8+ T cells in the tumor microenvironment (TME) and activate tumor-specific T …
functional CD8+ T cells in the tumor microenvironment (TME) and activate tumor-specific T …
[HTML][HTML] The multifaceted role of the CXC chemokines and receptors signaling axes in ALS pathophysiology
Amyotrophic lateral sclerosis (ALS) is a late-onset motor neuron disease with complex
genetic basis and still no clear etiology. Multiple intertwined layers of immune system …
genetic basis and still no clear etiology. Multiple intertwined layers of immune system …
New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer
SARS-CoV-2 infection is characterized by several clinical manifestations, ranging from the
absence of symptoms to severe forms that necessitate intensive care treatment. It is known …
absence of symptoms to severe forms that necessitate intensive care treatment. It is known …
Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival
P Karihtala, SK Leivonen, U Puistola… - Breast Cancer …, 2024 - Springer
Background Breast cancers exhibit considerable heterogeneity in their biology, immunology,
and prognosis. Currently, no validated, serum protein-based tools are available to evaluate …
and prognosis. Currently, no validated, serum protein-based tools are available to evaluate …
[HTML][HTML] Expressions of CXCR3 and PD-1 on T cells and their clinical relevance in colorectal cancer
S Wang, Y Zhang, G Chen, P Zhao, X Wang… - International …, 2024 - Elsevier
Purpose Clinical application of immunotherapy represented by Programmed Death-1 (PD-1)
monoclonal antibody has changed the treatment paradigm for colorectal cancer (CRC), and …
monoclonal antibody has changed the treatment paradigm for colorectal cancer (CRC), and …
Immune Cell Migration to Cancer
Immune cell migration is required for the development of an effective and robust immune
response. This elegant process is regulated by both cellular and environmental factors, with …
response. This elegant process is regulated by both cellular and environmental factors, with …
Keras/TensorFlow in Drug Design for Immunity Disorders
Homeostasis of the host immune system is regulated by white blood cells with a variety of
cell surface receptors for cytokines. Chemotactic cytokines (chemokines) activate their …
cell surface receptors for cytokines. Chemotactic cytokines (chemokines) activate their …
The Value of Prolactin, a Panel of Cytokines, and the Soluble Human Epidermal Growth Factor Receptor 2 in the Prediction of Rapid Progression and Shorter Survival …
S Cisoń-Jurek, P Czajka-Francuz, T Francuz… - Biomedicines, 2023 - mdpi.com
The prediction of colorectal cancer (CRC) response to palliative chemotherapy (CTH) is still
difficult. Patients at a higher risk of progression may benefit from more aggressive treatment …
difficult. Patients at a higher risk of progression may benefit from more aggressive treatment …